Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

October 31, 2011

Conditions
InfectionPrecancerous Condition
Interventions
BIOLOGICAL

Gardasil

week 0, 8, 24, 128

Trial Locations (8)

10010

Laser Surgery Care, New York

10021

New York Weill Cornell Cancer Center at Cornell University, New York

10461

Montefiore Medical Center, The Bronx

94143

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

98101

Benaroya Research Institute at Virginia Mason Medical Center, Seattle

90095-1793

UCLA Clinical AIDS Research and Education (CARE) Center, Los Angeles

80204-4507

Denver Health Medical Center, Denver

02118

Boston University Cancer Research Center, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

The Emmes Company, LLC

INDUSTRY

lead

AIDS Malignancy Consortium

NETWORK

NCT00513526 - Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection | Biotech Hunter | Biotech Hunter